Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

A synergy of liquid chromatography with high-resolution mass spectrometry and coagulation test for determination of direct oral anticoagulants for clinical and toxicological purposes

V. Maier, L. Slavík, P. Ondra

. 2021 ; 35 (10) : e5195. [pub] 20210621

Language English Country Great Britain

Document type Journal Article

Grant support
FNOl 00098892 Ministry of Health, Czech Republic - conceptual development of research organization

Direct oral anticoagulants are an alternative to anticoagulants based on vitamin K antagonists. Monitoring of direct oral anticoagulant concentration levels is necessary in specific cases (e.g. in emergency conditions, for determination of the cause of bleeding, adverse effects, risk of drug-direct oral anticoagulants interaction); therefore, a sensitive and specific method is needed. A methanol protein precipitation method followed by liquid chromatography with high-resolution mass spectrometry was developed for simultaneous separation and determination of apixaban, betrixaban, edoxaban, dabigatran, rivaroxaban and ximelagatran. The proposed method was fully validated in terms of linearity, the limits of detection and quantification, intra- and inter-day trueness and precision, recovery, matrix effect, process efficiency and stability. The method shows a strong correlation (Pearson's correlation coefficients > 0.92) with coagulation assays of apixaban, dabigatran and rivaroxaban (dilute thrombin time for gatrans and anti Xa factor (anti-Xa) activity for xabans). In addition, the developed method was applied for the identification and determination of apixaban and dabigatran in post-mortem serum samples. The developed method is a good alternative to coagulation tests which may show various interferences.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22003535
003      
CZ-PrNML
005      
20220127150127.0
007      
ta
008      
220113s2021 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1002/bmc.5195 $2 doi
035    __
$a (PubMed)34109658
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Maier, Vítězslav $u Department of Forensic Medicine and Medical Law, Faculty of Medicine and Dentistry, Palacký University Olomouc and University Hospital Olomouc, Olomouc, Czech Republic
245    12
$a A synergy of liquid chromatography with high-resolution mass spectrometry and coagulation test for determination of direct oral anticoagulants for clinical and toxicological purposes / $c V. Maier, L. Slavík, P. Ondra
520    9_
$a Direct oral anticoagulants are an alternative to anticoagulants based on vitamin K antagonists. Monitoring of direct oral anticoagulant concentration levels is necessary in specific cases (e.g. in emergency conditions, for determination of the cause of bleeding, adverse effects, risk of drug-direct oral anticoagulants interaction); therefore, a sensitive and specific method is needed. A methanol protein precipitation method followed by liquid chromatography with high-resolution mass spectrometry was developed for simultaneous separation and determination of apixaban, betrixaban, edoxaban, dabigatran, rivaroxaban and ximelagatran. The proposed method was fully validated in terms of linearity, the limits of detection and quantification, intra- and inter-day trueness and precision, recovery, matrix effect, process efficiency and stability. The method shows a strong correlation (Pearson's correlation coefficients > 0.92) with coagulation assays of apixaban, dabigatran and rivaroxaban (dilute thrombin time for gatrans and anti Xa factor (anti-Xa) activity for xabans). In addition, the developed method was applied for the identification and determination of apixaban and dabigatran in post-mortem serum samples. The developed method is a good alternative to coagulation tests which may show various interferences.
650    _2
$a aplikace orální $7 D000284
650    12
$a antikoagulancia $x aplikace a dávkování $x krev $x izolace a purifikace $x toxicita $7 D000925
650    _2
$a vyšetření krevní srážlivosti $x metody $7 D001780
650    _2
$a chromatografie kapalinová $x metody $7 D002853
650    _2
$a lidé $7 D006801
650    _2
$a lineární modely $7 D016014
650    _2
$a hmotnostní spektrometrie $x metody $7 D013058
650    _2
$a reprodukovatelnost výsledků $7 D015203
650    _2
$a senzitivita a specificita $7 D012680
655    _2
$a časopisecké články $7 D016428
700    1_
$a Slavík, Luděk $u Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacký University Olomouc and University Hospital Olomouc, Olomouc, Czech Republic
700    1_
$a Ondra, Peter $u Department of Forensic Medicine and Medical Law, Faculty of Medicine and Dentistry, Palacký University Olomouc and University Hospital Olomouc, Olomouc, Czech Republic
773    0_
$w MED00000817 $t Biomedical chromatography : BMC $x 1099-0801 $g Roč. 35, č. 10 (2021), s. e5195
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34109658 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220113 $b ABA008
991    __
$a 20220127150123 $b ABA008
999    __
$a ok $b bmc $g 1751097 $s 1154684
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 35 $c 10 $d e5195 $e 20210621 $i 1099-0801 $m BMC. Biomedical chromatography $n Biomed Chromatogr $x MED00000817
GRA    __
$a FNOl 00098892 $p Ministry of Health, Czech Republic - conceptual development of research organization
LZP    __
$a Pubmed-20220113

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...